Fat loss peptides are the hottest topic in the world of today’s peptides. Everyone is looking to drop a few pounds and their health could benefit from it.
Semaglutide is a peptide-based medication that has become one of the most important drugs in modern diabetes, obesity, and cardiovascular medicine. It belongs to a class known as GLP-1 receptor agonists, meaning it mimics the activity of the naturally occurring hormone glucagon-like peptide-1, or GLP-1. GLP-1 is released from the gastrointestinal tract after eating and […]
Continue Reading
Tirzepatide is one of the most important medications to emerge in modern metabolic medicine. It is a once-weekly injectable peptide-based medication that activates two hormone receptors involved in blood sugar control, appetite, and body weight: GIP — glucose-dependent insulinotropic polypeptide and GLP-1 — glucagon-like peptide-1. Because it targets both receptors simultaneously, tirzepatide is commonly described […]
Continue Reading
Cagrilintide peptide is one of the more interesting investigational peptides currently being developed for obesity, appetite regulation, weight management, and metabolic health. Unlike semaglutide, tirzepatide, and retatrutide, cagrilintide peptide is not primarily a GLP-1-based compound. Instead, it is a long-acting amylin analogue, meaning it is designed to mimic and enhance some of the biological effects […]
Continue Reading
Few experimental metabolic peptides have generated as much attention as retatrutide peptide. Developed by Eli Lilly and Company under the research designation LY3437943, retatrutide is being investigated primarily for obesity and related metabolic conditions. The excitement surrounding retatrutide peptide comes from its unusual mechanism of action. While semaglutide targets the GLP-1 receptor and tirzepatide targets […]
Continue Reading
